Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,419 | 416 | 99.2% |
| Education | $79.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,585 | 90 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,970 | 103 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $760.32 | 27 | $0 (2024) |
| GENZYME CORPORATION | $679.00 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $664.26 | 30 | $0 (2024) |
| Amgen Inc. | $456.56 | 32 | $0 (2024) |
| Genentech USA, Inc. | $407.14 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $385.29 | 19 | $0 (2024) |
| kaleo, Inc. | $240.32 | 11 | $0 (2023) |
| Optinose US, Inc. | $207.74 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,982 | 69 | AstraZeneca Pharmaceuticals LP ($840.30) |
| 2023 | $3,074 | 132 | GlaxoSmithKline, LLC. ($791.66) |
| 2022 | $2,001 | 88 | AstraZeneca Pharmaceuticals LP ($708.86) |
| 2021 | $564.18 | 23 | GlaxoSmithKline, LLC. ($123.06) |
| 2020 | $312.34 | 20 | AstraZeneca Pharmaceuticals LP ($75.52) |
| 2019 | $453.49 | 27 | Novartis Pharmaceuticals Corporation ($89.40) |
| 2018 | $568.30 | 30 | Genentech USA, Inc. ($150.62) |
| 2017 | $544.64 | 28 | PFIZER INC. ($125.89) |
All Payment Transactions
417 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: GENETIC DISEASE | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Immunology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Inflammation | ||||||
| 08/12/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Immunology | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 185 | 2,411 | $76,249 | $22,421 |
| 2022 | 7 | 142 | 1,897 | $48,228 | $16,603 |
| 2021 | 7 | 184 | 3,236 | $67,400 | $22,555 |
| 2020 | 6 | 171 | 3,407 | $44,875 | $19,564 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 29 | 580 | $17,860 | $6,490 | 36.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 18 | 1,302 | $19,196 | $4,081 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 46 | $10,620 | $3,992 | 37.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 23 | 395 | $15,580 | $3,170 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,302 | $2,902 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $3,006 | $1,198 | 39.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 24 | 28 | $2,374 | $550.98 | 23.2% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 17 | 19 | $311.25 | $37.28 | 12.0% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 21 | 460 | $12,420 | $5,026 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 47 | $8,930 | $4,229 | 47.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 15 | 1,055 | $13,715 | $3,312 | 24.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 16 | 276 | $8,832 | $2,183 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $2,640 | $1,265 | 47.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 19 | 25 | $1,575 | $556.64 | 35.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 13 | 14 | $115.50 | $32.06 | 27.8% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 35 | 590 | $14,539 | $7,125 | 49.0% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 29 | 2,122 | $26,767 | $6,537 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 31 | $5,890 | $3,062 | 52.0% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 35 | 302 | $9,208 | $1,954 | 21.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,274 | $1,591 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 24 | $3,093 | $1,468 | 47.5% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 18 | 152 | $3,629 | $819.28 | 22.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 29 | 2,302 | $17,841 | $7,426 | 41.6% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 36 | 374 | $6,826 | $3,710 | 54.4% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 32 | 441 | $8,820 | $3,053 | 34.6% |
About Dr. Michael Saavedra, MD
Dr. Michael Saavedra, MD is a Allergy & Immunology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497946685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Saavedra, MD has received a total of $9,499 in payments from pharmaceutical and medical device companies, with $1,982 received in 2024. These payments were reported across 417 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($9,419).
As a Medicare-enrolled provider, Saavedra has provided services to 682 Medicare beneficiaries, totaling 10,951 services with total Medicare billing of $81,144. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Phoenix, AZ
- Active Since 08/05/2007
- Last Updated 02/05/2026
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1497946685
Products in Payments
- FASENRA (Biological) $1,492
- DUPIXENT (Biological) $1,380
- TEZSPIRE (Biological) $1,124
- TRELEGY ELLIPTA (Drug) $1,052
- NUCALA (Biological) $538.26
- Xolair (Biological) $407.14
- XOLAIR (Drug) $406.83
- CUVITRU (Biological) $302.57
- XOLAIR (Biological) $257.43
- AUVI-Q (Drug) $213.20
- Xhance (Drug) $207.74
- EUCRISA (Drug) $161.46
- Haegarda (Biological) $144.33
- AIRSUPRA (Drug) $135.00
- TAKHZYRO (Biological) $127.29
- SYMBICORT (Drug) $119.93
- FASENRA (Drug) $102.38
- AREXVY (Drug) $96.19
- DUPIXENT DUPILUMAB INJECTION (Biological) $86.05
- Prolastin-C Liquid (Biological) $81.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Phoenix
Dr. Rahul Rishi, D.o, D.O
Allergy & Immunology — Payments: $18,283
Reimus Valencia, Do, DO
Allergy & Immunology — Payments: $10,983
Dr. Allan Wachter, Md, MD
Allergy & Immunology — Payments: $3,834
Mark Schubert, Md, MD
Allergy & Immunology — Payments: $3,662
Claudia Gaefke, Md, MD
Allergy & Immunology — Payments: $3,604
Jeffrey Leitner, M.d, M.D
Allergy & Immunology — Payments: $2,919